This would enable someone with presbyopia to see better. Pilocarpine, itself, is not a new application in ophthalmology, or even, presbyopia. It has been used to treat glaucoma, though its use waned ...

Regulatory approval to Entod Pharma for PresVu, meant to treat presbyopia, was revoked as the firm marketed it as a ...

Mumbai-based Entod Pharmaceuticals said on Thursday that it has decided to move the court to challenge the national drug regulator’s suspension of permission to manufacture and market its pilocarpine ...

Company response: One doctor evaluated the drug product compared to the reading glasses. DCGI response: “You are informed that the Pilocarpine Hydrochloride Ophthalmic Solution USP 1.25 per cent w/ is ...

The Drug Controller General of India (DCGI) has suspended the licence for the eyedrop meant to reduce the need for reading glasses in people with Presbyopia. The licence of eyedrop PresVu, ...

On September 4, the drug regulator had asked for an explanation from the company for the claims it made in the press following which the drug-maker also submitted its response.

The Drugs Controller General of India (DCGI) stated in an order dated September 10 that the Directorate had approved on August 20 for the production and distribution of Pilocarpine Hydrochloride ...

PresVu has been suspended by the DCGI due to misleading marketing claims that the eye drops can "cure" near-sightedness.

In response to the various alleged misleading claims made by Entod Pharma in respect to its Opthalmologic product, Drugs ...

The Drug Controller General of India has suspended the manufacturing licence of PresVu eye drops Read on to know why it was suspended ...

Entod Pharma to challenge DCGI's suspension of permission for PresVu in court: Our Bureau, New Delhi Thursday, September 12, 2024, 13:45 Hrs [IST] Entod Pharmaceuticals announced ...

The Directorate General of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), has ...